Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

98.96
Delayed Data
As of 4:00pm ET
 -1.84 / -1.83%
Today’s Change
62.96
Today|||52-Week Range
153.99
-22.11%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues50.6M41.1M47.2M89.9M
 
 
 
 
 
Depreciation And Amortization11.9M19.1M15.1M13.4M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses222.8M318.1M456.6M576.6M
 
 
 
 
 
Research And Development190.2M276.5M382.4M390.6M
 
 
 
 
 
Total Operating Expenses234.8M337.1M471.7M590.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-184.2M-296.0M-424.6M-500.1M
 
 
 
 
 
Extraordinary Charge-220.8M0.000.000.00
 
 
Interest Expense On Debt0.000.001.2M800.0K
 
 
 
Other Expenses1.8M76.0K7.4M-2.2M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-400.6M-290.1M-410.1M-490.9M
 
 
 
 
 
Income Taxes-40.2M0.000.000.00
 
 
Net Income-360.4M-290.1M-410.1M-490.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS74.3M84.0M85.6M90.6M
 
 
 
 
 
Shares To Calculate EPS Diluted74.3M84.0M85.6M90.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$4.85-$3.45-$4.79-$5.42
 
 
 
 
 
EPS Diluted-$4.85-$3.45-$4.79-$5.42